2013

High school students discover how research at IDIBELL is

Leave a Comment / Outreach and education / By

On April 16th science students of the French School of Barcelona visited the IDIBELL to see firsthand how a biomedical research center works. Researchers of the neurometabolic diseases group explained to students the research of a rare disease, the X-linked adrenoleukodistrophy, from basic research, to the investigation with animal models and clinical trial patients. The […]

High school students discover how research at IDIBELL is Read More »

Identified as responsible for breast and ovarian hereditary cancer three BRCA1 mutations

Leave a Comment / Cancer, Hereditary cancer , Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

Researchers of the hereditary cancer research group at the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) conducted a functional and structural study of seven missense variants of the BRCA1 gene concluding that three of these variants are pathogenic, linked to the risk of suffering breast or ovarian cancer. The study

Identified as responsible for breast and ovarian hereditary cancer three BRCA1 mutations Read More »

Laura Valle awarded ‘young researcher in human genetics’

Leave a Comment / Cancer, Hereditary cancer , Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

The researcher of the hereditary cancer group at IDIBELL, Laura Valle, has been awarded ‘young researcher in human genetics’ of the Spanish Association of Human Genetics (AEGH). The award was presented on April 12 in Madrid, under the XXVII Congress of the Association, which was held between 10 and 12 April. The award recognizes the

Laura Valle awarded ‘young researcher in human genetics’ Read More »

Rui Benedito: ”We are developing new tools to dissect the molecular mechanisms of angiogenesis”

Leave a Comment / Innovation, Outreach and education / By

Researcher Rui Benedito of the National Center for Cardiovascular Research Carlos III (CNIC) Madrid explained his research on the regulation of angiogenesis through the Notch signalling pathway on April 5 at a conference cycle framed within IDIBELL seminars. Angiogenesis is the formation of new blood vessels from pre-existing vessels. Benedito studies this process that normally

Rui Benedito: ”We are developing new tools to dissect the molecular mechanisms of angiogenesis” Read More »

Pathological gambling is associated with age

Leave a Comment / Neuroscience Area, Neuroscience Program, Psychiatry and Mental Health , Psychoneurobiology of Eating and Addictive Behaviours / By

Researchers of the Psychiatry and Mental Health research group at the Bellvitge Biomedical Research Institute (IDIBELL), in the Bellvitge University Hospital, have shown that patient age influences the onset of pathological gambling disorder and its clinical course. The study results were published in the Journal of Gambling Studies. Personality traits The study was conducted with

Pathological gambling is associated with age Read More »

Kevin M. Ryan: “The goal of a science basic lab should be transfer knowledge to therapeutic improvements for patients”

Leave a Comment / Innovation, Outreach and education / By

Cell death is the field of study of the researcher Kevin M. Ryan at The Beatson Institute for Cancer Research in Glasgow (UK). On Friday, March 22 within the cycle of seminars IDIBELL, Ryan explained the latest advances in his research of one of the mechanisms of cell death: autophagy. The goal of the laboratory

Kevin M. Ryan: “The goal of a science basic lab should be transfer knowledge to therapeutic improvements for patients” Read More »

IDIBELL and VHIR licenses Histocell a patent for acute respiratory diseases with stem cells

Leave a Comment / Genes, Disease and Therapy Program, Immune-inflammatory Processes and Gene Therapeutics, Translational Medicine Area / By

The Bellvitge Biomedical Research Institute (IDIBELL) has signed a licensing agreement with the Spanish biotech company Histocell to make use of a patent for the treatment of acute pulmonary diseases with mesenchymal stem cells. These cells, administered intravenously, have the ability to go directly to the damaged lungs, acting as a “smart drug”. To enhance

IDIBELL and VHIR licenses Histocell a patent for acute respiratory diseases with stem cells Read More »

Endoscopy treatments save hospital admissions

Leave a Comment / Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention Program, Hepato-biliary-pancreatic pathology , Traslacional Medicine / By

Advances in therapeutic endoscopy techniques, with the development of a score of innovative procedures are enabling increasingly performing digestive disorders interventions without resorting to conventional surgery with hospitalization. “Digestive endoscopy is less invasive than conventional surgical techniques as it is done by inserting a tube with a camera through the mouth. Such treatments are gaining

Endoscopy treatments save hospital admissions Read More »

Ángel Carracedo: ”Only 50% of first-line drugs are effective”

Leave a Comment / Uncategorised / By

The Professor of Legal Medicine and director of the Genomic Medicine lab at the University of Santiago de Compostela, Angel Carracedo, talked of the future challenges of the field of pharmacogenetics in the clinic. It was last March 15 at a conference within the framework of the IDIBELL seminars. Currently only 50% of first-line drugs

Ángel Carracedo: ”Only 50% of first-line drugs are effective” Read More »

Discovered the epigenetic mechanism through which protein SirT2 regulates cell cycle progression and genomic stability

Leave a Comment / Uncategorised / By

The study of IDIBELL researchers confirms antitumor properties of sirtuin 2 Clinical applications of SIRT2 Control of epigenetic marks Article’s reference The Tumor supressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation.

Discovered the epigenetic mechanism through which protein SirT2 regulates cell cycle progression and genomic stability Read More »

Scroll to Top